191 related articles for article (PubMed ID: 17152048)
1. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.
Karsai S; Abel U; Roesch-Ely M; Affolter A; Hofele C; Joos S; Plinkert PK; Bosch FX
J Pathol; 2007 Feb; 211(3):314-22. PubMed ID: 17152048
[TBL] [Abstract][Full Text] [Related]
2. Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers.
Grüttgen A; Reichenzeller M; Jünger M; Schlien S; Affolter A; Bosch FX
J Pathol; 2001 Jul; 194(3):311-7. PubMed ID: 11439363
[TBL] [Abstract][Full Text] [Related]
3. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
4. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein.
Leng K; Schlien S; Bosch FX
J Oral Pathol Med; 2006 Jan; 35(1):19-24. PubMed ID: 16393249
[TBL] [Abstract][Full Text] [Related]
5. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit.
Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Alam N; Sikdar N; Roy B; Roychoudhury S; Panda CK
J Pathol; 2009 Feb; 217(3):408-19. PubMed ID: 19023882
[TBL] [Abstract][Full Text] [Related]
6. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
7. [Biallelic inactivation of the p16-Gen in a metachronous triple carcinoma in the oropharyngeal region].
Motsch C; Giers A; Boltze C; Evert M; Freigang B; Roessner A; Schneider-Stock R
Laryngorhinootologie; 2004 Jan; 83(1):55-60. PubMed ID: 14740307
[TBL] [Abstract][Full Text] [Related]
8. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
9. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
Yarbrough WG
Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
[TBL] [Abstract][Full Text] [Related]
10. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
[TBL] [Abstract][Full Text] [Related]
11. p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas.
O'Regan EM; Toner ME; Finn SP; Fan CY; Ring M; Hagmar B; Timon C; Smyth P; Cahill S; Flavin R; Sheils OM; O'Leary JJ
Hum Pathol; 2008 Mar; 39(3):452-8. PubMed ID: 18261630
[TBL] [Abstract][Full Text] [Related]
12. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.
Wiest T; Schwarz E; Enders C; Flechtenmacher C; Bosch FX
Oncogene; 2002 Feb; 21(10):1510-7. PubMed ID: 11896579
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
Kanellou P; Zaravinos A; Zioga M; Spandidos DA
Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
[TBL] [Abstract][Full Text] [Related]
14. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
[TBL] [Abstract][Full Text] [Related]
15. p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.
Ganly I; Soutar DS; Brown R; Kaye SB
Br J Cancer; 2000 Jan; 82(2):392-8. PubMed ID: 10646894
[TBL] [Abstract][Full Text] [Related]
16. p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis.
Suzuki H; Sugimura H; Hashimoto K
J Oral Maxillofac Surg; 2006 Nov; 64(11):1617-23. PubMed ID: 17052587
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
[TBL] [Abstract][Full Text] [Related]
18. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.
Young RJ; Rischin D; Fisher R; McArthur GA; Fox SB; Peters LJ; Corry J; Lim A; Waldeck K; Solomon B
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1230-7. PubMed ID: 21467228
[TBL] [Abstract][Full Text] [Related]
19. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of p16 genetic alterations in head and neck tumours.
Miracca EC; Kowalski LP; Nagai MA
Br J Cancer; 1999 Oct; 81(4):677-83. PubMed ID: 10574255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]